In 2024, the forecast for chronic liver diseases and cirrhosis mortality in Canada stands at 3.98 thousand deaths. This is projected to incrementally rise to 4.23 thousand by 2028, marking a consistent upward trend. Between 2024 and 2025, the year-on-year increase is approximately 1.76%, with subsequent years following a similar pattern. The compound annual growth rate (CAGR) over this five-year span is approximately 1.22%, indicating a steady, albeit modest, rise in mortality attributed to these health conditions.
Future trends to watch for include advancements in medical interventions that could potentially curb this growth, as well as public health initiatives aimed at reducing risk factors associated with chronic liver diseases and cirrhosis. Additionally, shifts in demographic factors and healthcare policies could play pivotal roles in altering these projections.
